Literature DB >> 9555003

Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.

B Schütz1, M K Schäfer, L E Eiden, E Weihe.   

Abstract

The vesicular monoamine transporters VMAT1 and VMAT2 are essential components of monoaminergic neurons and endocrine cells whose expression in development may provide insight into lineage pathways for chemical coding in the diffuse neuroendocrine system. Thus, the brain is a compartment in which only monoaminergic neurons are generated, the gut epithelium generates only endocrine monoamine-containing cells, and the neural crest produces both autonomic monoaminergic neurons and endocrine/paracrine monoaminergic cells. Selection of either the VMAT1 or VMAT2 isoform was examined in these three compartments during development. In the central nervous system VMAT2, but not VMAT1, was expressed in neuroepithelial cells by embryonic day 12 (E12), and all major monoaminergic cell groups by E14. Thalamocortical and hypothalamic neurons that do not express VMAT2 in adulthood were transiently VMAT2-positive from E16 to postnatal day 6 (P6). EC cells of the gut expressed exclusively VMAT1 from E19 on, while histamine-containing enterochromaffin-like (ECL) cells of the stomach expressed only VMAT2 by E19 and throughout postnatal development. VMAT2 and the vesicular acetylcholine transporter VAChT were co-expressed in early development of the primary sympathetic chain as well as in the cranial parasympathetic ganglia. VAChT was progressively restricted to a small population of VMAT2-negative post-ganglionic neurons in the adult sympathetic chain, while VMAT2 expression persisted in sympathetic principal ganglion and SIF cells but was eventually extinguished in cranial parasympathetic ganglia. VMAT1 was co-expressed with VAChT and VMAT2 mRNA in the primary sympathetic chain on E12, but progressively restricted to small intensely fluorescent (SIF) and chromaffin cells thereafter. Thus, expression of the vesicular amine transporters appropriate for chemical coding of brain neurons and gut endocrine cells are pre-determined developmentally. In contrast, the neural crest-derived sympathoadrenal and neural crest-derived parasympathetic cell groups examined here initially co-express two or more vesicular amine transporters, followed by extinction of the inappropriate transporter(s) later in development. Some neural crest-derived neuroendocrine cell populations continue to express both isoforms of VMAT even in adulthood. Lineage distinctions in ontogeny of vesicular amine transporter expression in brain, gut and autonomic nervous system make it likely that the same genes are regulated differently in the autonomic nervous system compared to brain and gut.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555003     DOI: 10.1016/s0165-3806(97)00196-x

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  13 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  Vesicular monoamine transporters (VMATs) in adrenal chromaffin cells: stress-triggered induction of VMAT2 and expression in epinephrine synthesizing cells.

Authors:  Andrej Tillinger; Anne Sollas; Lidia I Serova; Richard Kvetnansky; Esther L Sabban
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

3.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

Review 4.  Localization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.

Authors:  Martin K-H Schafer; Eberhard Weihe; Lee E Eiden
Journal:  Adv Pharmacol       Date:  2013

5.  Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system.

Authors:  Eberhard Weihe; Burkhard Schütz; Wolfgang Hartschuh; Martin Anlauf; Martin K Schäfer; Lee E Eiden
Journal:  J Comp Neurol       Date:  2005-11-21       Impact factor: 3.215

6.  Satb2-independent acquisition of the cholinergic sudomotor phenotype in rodents.

Authors:  Burkhard Schütz; Martin K-H Schäfer; Markus Gördes; Lee E Eiden; Eberhard Weihe
Journal:  Cell Mol Neurobiol       Date:  2014-09-20       Impact factor: 5.046

7.  Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons.

Authors:  Dong-Youn Hwang; Sunghoi Hong; Joo-Won Jeong; Sangdun Choi; Hansoo Kim; Jangwoo Kim; Kwang-Soo Kim
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

8.  Serotonin released from amacrine neurons is scavenged and degraded in bipolar neurons in the retina.

Authors:  Kanika Ghai; Christopher Zelinka; Andy J Fischer
Journal:  J Neurochem       Date:  2009-07-08       Impact factor: 5.372

Review 9.  Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.

Authors:  F Sánchez-Jiménez; M V Ruiz-Pérez; J L Urdiales; M A Medina
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 10.  The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine.

Authors:  Lee E Eiden; Martin K-H Schäfer; Eberhard Weihe; Burkhard Schütz
Journal:  Pflugers Arch       Date:  2003-06-24       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.